Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MSF.F
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 1.95 1.24 1.22
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -15.65 1.79 2.12
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value 6.26 34.07 32.06
Cash -1.18 10.77 10.90
Capex -12.52 -1.47 -1.31
Free Cash Flow 129.96 2.82 1.23
Revenue -0.25 8.32 8.34
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin 2.52 0.70 0.68
Operating Margin 2.30 0.45 0.44
ROA -2.53 0.05 0.05
ROE -5.58 0.09 0.09
ROIC -0.38 0.07 0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MSF.F is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MSF.F is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MSF.F is permitted for members.